Aesculus is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Marco Pharma International Llc.. The primary component is Argentina Anserina Flowering Top; Horse Chestnut; Ustilago Maydis; Claviceps Purpurea Sclerotium; Ruta Graveolens Whole.
Product ID | 60986-1027_6cda0749-9760-4a28-abf8-dedae45a915a |
NDC | 60986-1027 |
Product Type | Human Otc Drug |
Proprietary Name | Aesculus |
Generic Name | Potentilla Anserina, Aesculus Hippocastanum, Ustilago Maidis, Secale Cornutum, Ruta Graveolens |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 1992-03-01 |
Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
Labeler Name | Marco Pharma International LLC. |
Substance Name | ARGENTINA ANSERINA FLOWERING TOP; HORSE CHESTNUT; USTILAGO MAYDIS; CLAVICEPS PURPUREA SCLEROTIUM; RUTA GRAVEOLENS WHOLE |
Active Ingredient Strength | 1 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-02-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-02-27 |
Inactivation Date | 2020-01-31 |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-02-27 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ARGENTINA ANSERINA FLOWERING TOP | 1 [hp_X]/mL |
SPL SET ID: | 99365ce6-f7d1-483b-952b-2ef6a17d39ab |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
53645-1370 | Aesculus | Aesculus |
60986-1027 | Aesculus | Potentilla Anserina, Aesculus Hippocastanum, Ustilago Maidis, Secale Cornutum, Ruta Graveolens |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AESCULUS 85761692 4886218 Live/Registered |
RBZ Vineyards, LLC 2012-10-23 |
AESCULUS 77803449 not registered Dead/Abandoned |
Good, Albert L. 2009-08-12 |
AESCULUS 77750473 not registered Dead/Abandoned |
Albert L. Good 2009-06-02 |